University of Missouri–Kansas City at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Missouri–Kansas City brings 11 presentations to ASH 2026 in New Orleans. Its program centres on real-world outcomes in sickle cell disease, thrombosis and blood cancers. It covers care gaps such as hydroxyurea underuse and heart risks after CAR-T therapy.
| Organization | ASH 2026 Attendance |
|---|---|
University of Missouri–Kansas City Kansas City, MO | |
Public research university in Kansas City, Missouri. | Oral Sat Dec 12 9:30am–11:00am Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University of Missouri–Kansas City
Tell us what you sell and we’ll find the people at University of Missouri–Kansas City most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction